Tirzepatide Approved by Brazil's ANVISA: A Complete Guide to the Newest GLP-1 Weight Loss Option
Brazil's ANVISA has approved Tirzepatide (Tirzec) for weight loss. Here's everything you need to know about this dual-agonist medication, how it works, and what to expect.